Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma
about
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Adult brain cancer in the U.S. black population: a Surveillance, Epidemiology, and End Results (SEER) analysis of incidence, survival, and trendsHigh-dose cytarabine salvage therapy for recurrent primary CNS lymphoma.Progress in central nervous system lymphomas.High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).Response-adapted treatment with upfront high-dose chemotherapy followed by autologous stem-cell transplantation rescue or consolidation phase high-dose methotrexate for primary central nervous system lymphoma: a long-term mono-center studyGene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing AnalysesNew approaches in primary central nervous system lymphoma.Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma.Risk factors for intraocular involvement in patients with primary central nervous system lymphoma.The Challenge of Primary Central Nervous System Lymphoma.Primary central nervous system lymphoma: essential points in diagnosis and management.The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system - a one-decade single-centre experience.Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma.Advances in the treatment of newly diagnosed primary central nervous system lymphomas.Reply to M.C. Chamberlain.A focus on pharmacotherapy for primary central nervous system lymphoma.[Primary CNS lymphoma. Progress in the diagnostics and therapy].Combined alkylation and histone deacetylase inhibition with EDO-S101 has significant therapeutic activity against brain tumors in preclinical models.
P2860
Q28078539-77AE9170-CAE6-4B0E-81B3-4A8E15819CE5Q28393814-D575041D-1D7A-4F68-ADE8-8DD78A8E2F95Q33427514-DA846F7F-7002-427D-8F5F-2E674E9FCA6EQ33934406-2281231F-0F3A-484D-AFD1-4A565F50625BQ35995248-BBE52AC3-D8A0-49E0-80F0-CC9A17180D20Q36674028-D288C466-85BB-4D1F-8FBD-50CC7BBEB475Q36939219-49602318-D73F-48D9-9085-F9AC7F237CBCQ37088471-682B4D95-73DE-4FF6-A0AC-2A3CC0E87681Q37362633-5B25B021-920C-41BF-BE8B-AC6CD9DD6288Q38239533-556BE5AE-A20C-4BB6-BC38-5CDCF627B3CCQ39020652-AA108BC3-0533-472E-8309-C86B570079ECQ39185721-3F1B4CE6-5B7D-4858-A355-837C66FFA787Q41420462-84554E9B-8001-442D-9EE6-7470A0A0E6E3Q41593361-AB8ECE04-5634-4038-98C2-1E88CB833A62Q42377771-453E4469-EE82-4CD9-871E-6CB315C10FF5Q42426074-3951AB05-4691-473A-B4EE-D9091CBD7C2CQ44251785-39AF1877-5420-4DB4-AB98-3588501B114DQ52866187-3549937B-1117-4550-B75E-EF820F29AA6CQ55359395-991251C1-307B-45F4-A9E3-58C900599402
P2860
Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Beyond high-dose methotrexate ...... gents for primary CNS lymphoma
@ast
Beyond high-dose methotrexate ...... gents for primary CNS lymphoma
@en
Beyond high-dose methotrexate ...... gents for primary CNS lymphoma
@nl
type
label
Beyond high-dose methotrexate ...... gents for primary CNS lymphoma
@ast
Beyond high-dose methotrexate ...... gents for primary CNS lymphoma
@en
Beyond high-dose methotrexate ...... gents for primary CNS lymphoma
@nl
prefLabel
Beyond high-dose methotrexate ...... gents for primary CNS lymphoma
@ast
Beyond high-dose methotrexate ...... gents for primary CNS lymphoma
@en
Beyond high-dose methotrexate ...... gents for primary CNS lymphoma
@nl
P2093
P2860
P3181
P356
P1433
P1476
Beyond high-dose methotrexate ...... gents for primary CNS lymphoma
@en
P2093
J. L. Rubenstein
M. Ponzoni
T. T. Batchelor
P2860
P304
P3181
P356
10.1093/ANNONC/MDT385
P407
P577
2014-02-01T00:00:00Z